|
|
|
42
|
1132JT
|
ATORVASTATIN 20MG TAB (MOR)
|
ATORVASTATIN
|
ATORVASTATIN
|
30'S
|
A
|
1.58
|
0.05
|
TAB
|
30
|
BLIS
|
MOR
|
MORACEAE
|
CWS
|
CAPSULE WHOLESALE
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2026-04-01
|
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
42
|
1134BD
|
ATORVASTATIN 80MG TAB (MOR)
|
ATORVASTATIN
|
ATORVASTATIN
|
30'S
|
A
|
3.04
|
0.10
|
TAB
|
30
|
BLIS
|
MOR
|
MORACEAE
|
CWS
|
CAPSULE WHOLESALE
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2026-04-01
|
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
41
|
15929
|
CHLORPROMAZINE 50MG TAB (TOR)
|
CHLORPROMAZINE
|
CHLORPROMAZINE
|
500'S
|
A
|
264.2755
|
0.5286
|
TAB
|
90
|
BOTT
|
TOR
|
TORRENT PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160824
|
PHENOTHIAZINES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
PHENOTHIAZINES
|
|
|
|
|
40
|
5692K
|
ACYCLOVIR 5% OINT (TOR/AHI)
|
ACYCLOVIR
|
ACYCLOVIR
|
15G
|
C
|
69.32
|
69.32
|
OINT
|
0
|
TUBE
|
TOR
|
TORRENT PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2022-04-01
|
2024-03-31
|
|
TOPICAL
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
5692K
|
ACYCLOVIR 5% OINT (TOR)
|
ACYCLOVIR
|
ACYCLOVIR
|
15G
|
C
|
69.32
|
69.3173
|
TUBE
|
2
|
BOX
|
TOR
|
TORRENT PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2024-04-01
|
2026-03-31
|
|
TOPICAL
|
0
|
NUCLEOSIDES AND NUCLEOTIDES
|
|
|
|
|
40
|
A671CE
|
MONTELUKAST CHEWABLE 10MG TAB (TOR/AHI) MONTE
|
MONTELUKAST
|
MONTELUKAST CHEWABLE
|
90'S
|
A
|
14.81
|
0.16
|
TABLET
|
30
|
TAB
|
TOR
|
TORRENT PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
481024
|
LEUKOTRIENE MODIFIERS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
RESPIRATORY TRACT AGENTS
|
|